Oxford Gene Technology Revenue and Competitors

Oxford Gene Technology (OGT) provides world-class genetics research solutions to leading clinical and academic research institutions.\n\nFounded by Professor Sir Edwin Southern, OGT has helped pioneer the molecular medicine revolution by enabling smarter decision making in human healthcare. With customers in over 60 countries worldwide and ambitious expansion plans, OGT has a strong reputation and increasing share in the large and growing genomic medicine market. \n\nThe Group's CytoSureâ?¢, Cytocell® and SureSeqâ?¢ range of microarray, FISH and next generation sequencing products deliver high-quality, high-throughput genetic analysis, enabling accurate identification of the causative variation underlying genetic disease.\n\nOGT is a rapidly growing company with state-of-the-art facilities and over 100 employees based at our head-office in Begbroke, Oxfordshire, or at our Cytocell office in Cambridge, Cambridgeshire. Since its acquisition in 2017, OGT are a subsidiary of the highly successful Sysmex Corporation, currently ranked in the top 10 global inâ??vitro diagnostic companies.